538 related articles for article (PubMed ID: 30172452)
1. Patient-derived induced pluripotent stem cells for models of cancer and cancer stem cell research.
Chao HM; Chern E
J Formos Med Assoc; 2018 Dec; 117(12):1046-1057. PubMed ID: 30172452
[TBL] [Abstract][Full Text] [Related]
2. Reactivation of Endogenous Genes and Epigenetic Remodeling Are Barriers for Generating Transgene-Free Induced Pluripotent Stem Cells in Pig.
Choi KH; Park JK; Son D; Hwang JY; Lee DK; Ka H; Park J; Lee CK
PLoS One; 2016; 11(6):e0158046. PubMed ID: 27336671
[TBL] [Abstract][Full Text] [Related]
3. Inducing goat pluripotent stem cells with four transcription factor mRNAs that activate endogenous promoters.
Chen H; Zuo Q; Wang Y; Song J; Yang H; Zhang Y; Li B
BMC Biotechnol; 2017 Feb; 17(1):11. PubMed ID: 28193206
[TBL] [Abstract][Full Text] [Related]
4. Reprogramming bladder cancer cells for studying cancer initiation and progression.
Iskender B; Izgi K; Canatan H
Tumour Biol; 2016 Oct; 37(10):13237-13245. PubMed ID: 27456363
[TBL] [Abstract][Full Text] [Related]
5. Induction of dental pulp-derived induced pluripotent stem cells in the absence of c-Myc for differentiation into neuron-like cells.
Chang YC; Li WC; Twu NF; Li HY; Lo WL; Chang YL; Lee YY; Lin CF; Shih YH; Chen MT
J Chin Med Assoc; 2014 Dec; 77(12):618-25. PubMed ID: 25441769
[TBL] [Abstract][Full Text] [Related]
6. Enhanced human somatic cell reprogramming efficiency by fusion of the MYC transactivation domain and OCT4.
Wang L; Huang D; Huang C; Yin Y; Vali K; Zhang M; Tang Y
Stem Cell Res; 2017 Dec; 25():88-97. PubMed ID: 29125994
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of Induction: Induced Pluripotent Stem Cells (iPSCs).
Singh VK; Kumar N; Kalsan M; Saini A; Chandra R
J Stem Cells; 2015; 10(1):43-62. PubMed ID: 26665937
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional and epigenetic mechanisms of cellular reprogramming to induced pluripotency.
van den Hurk M; Kenis G; Bardy C; van den Hove DL; Gage FH; Steinbusch HW; Rutten BP
Epigenomics; 2016 Aug; 8(8):1131-49. PubMed ID: 27419933
[TBL] [Abstract][Full Text] [Related]
9. Identification of New Transcription Factors that Can Promote Pluripotent Reprogramming.
Huang P; Zhu J; Liu Y; Liu G; Zhang R; Li D; Pei D; Zhu P
Stem Cell Rev Rep; 2021 Dec; 17(6):2223-2234. PubMed ID: 34448118
[TBL] [Abstract][Full Text] [Related]
10. Reprogramming of mouse fibroblasts into induced pluripotent stem cells with Nanog.
Moon JH; Yun W; Kim J; Hyeon S; Kang PJ; Park G; Kim A; Oh S; Whang KY; Kim DW; Yoon BS; You S
Biochem Biophys Res Commun; 2013 Feb; 431(3):444-9. PubMed ID: 23333380
[TBL] [Abstract][Full Text] [Related]
11. Efficient induction of pluripotent stem cells from menstrual blood.
Li Y; Li X; Zhao H; Feng R; Zhang X; Tai D; An G; Wen J; Tan J
Stem Cells Dev; 2013 Apr; 22(7):1147-58. PubMed ID: 23151296
[TBL] [Abstract][Full Text] [Related]
12. Serum starvation-induced cell cycle synchronization stimulated mouse rDNA transcription reactivation during somatic cell reprogramming into iPSCs.
Zhao Q; Wu Y; Shan Z; Bai G; Wang Z; Hu J; Liu L; Li T; Shen J; Lei L
Stem Cell Res Ther; 2016 Aug; 7(1):112. PubMed ID: 27515169
[TBL] [Abstract][Full Text] [Related]
13. Current status in cancer cell reprogramming and its clinical implications.
Izgi K; Canatan H; Iskender B
J Cancer Res Clin Oncol; 2017 Mar; 143(3):371-383. PubMed ID: 27620745
[TBL] [Abstract][Full Text] [Related]
14. Malignant germ cell-like tumors, expressing Ki-1 antigen (CD30), are revealed during in vivo differentiation of partially reprogrammed human-induced pluripotent stem cells.
Griscelli F; Féraud O; Oudrhiri N; Gobbo E; Casal I; Chomel JC; Biéche I; Duvillard P; Opolon P; Turhan AG; Bennaceur-Griscelli A
Am J Pathol; 2012 May; 180(5):2084-96. PubMed ID: 22425713
[TBL] [Abstract][Full Text] [Related]
15. Reprogramming of retinoblastoma cancer cells into cancer stem cells.
Yue F; Hirashima K; Tomotsune D; Takizawa-Shirasawa S; Yokoyama T; Sasaki K
Biochem Biophys Res Commun; 2017 Jan; 482(4):549-555. PubMed ID: 27856246
[TBL] [Abstract][Full Text] [Related]
16. Sox2 expression effects on direct reprogramming efficiency as determined by alternative somatic cell fate.
Yamaguchi S; Hirano K; Nagata S; Tada T
Stem Cell Res; 2011 Mar; 6(2):177-86. PubMed ID: 21130722
[TBL] [Abstract][Full Text] [Related]
17. Inducing pluripotency in vitro: recent advances and highlights in induced pluripotent stem cells generation and pluripotency reprogramming.
Rony IK; Baten A; Bloomfield JA; Islam ME; Billah MM; Islam KD
Cell Prolif; 2015 Apr; 48(2):140-56. PubMed ID: 25643745
[TBL] [Abstract][Full Text] [Related]
18. Induced Pluripotent Stem Cells With Six Reprogramming Factors From Prairie Vole, Which Is an Animal Model for Social Behaviors.
Katayama M; Hirayama T; Horie K; Kiyono T; Donai K; Takeda S; Nishimori K; Fukuda T
Cell Transplant; 2016; 25(5):783-96. PubMed ID: 26777120
[TBL] [Abstract][Full Text] [Related]
19. Metabolome Profiling of Partial and Fully Reprogrammed Induced Pluripotent Stem Cells.
Park SJ; Lee SA; Prasain N; Bae D; Kang H; Ha T; Kim JS; Hong KS; Mantel C; Moon SH; Broxmeyer HE; Lee MR
Stem Cells Dev; 2017 May; 26(10):734-742. PubMed ID: 28346802
[TBL] [Abstract][Full Text] [Related]
20. Reprogramming of endometrial adult stromal cells in the presence of a ROCK inhibitor, thiazovivin, could obtain more efficient iPSCs.
Mohseni R; Shoae-Hassani A; Verdi J
Cell Biol Int; 2015 May; 39(5):515-8. PubMed ID: 25490878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
